OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-RNF144B antibodies

Anti-RNF144B TRUEMAB Antibody Clone OTI1E1

TrueMAB™ Antibodies - Made against Authentic Protein Antigens

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA500712 RNF144B (IBRDC2) mouse monoclonal antibody, clone OTI1E1 (formerly 1E1) 100ul $325 In Stock
CF500712 Carrier-free (BSA/glycerol-free) RNF144B mouse monoclonal antibody, clone OTI1E1 (formerly 1E1) 100ug $450 3-4 weeks
Add to Shopping Cart
spacer
FC(1)

OriGene Data

ImmunogenHuman recombinant protein fragment corresponding to amino acids 1-256 of human RNF144B (NP_877434) produced in E. coli.
Clone NameClone OTI1E1 IsotypeIgG1
Species ReactivityHuman Concentration0.82 mg/ml
Guaranteed Application *FC Suggested DilutionsFLOW 1:100,
Predicted MW Explanation 33.5 kDa
BufferPBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Purification Purified from mouse ascites fluids by affinity chromatography

Reference Data

Target NameHomo sapiens ring finger protein 144B (RNF144B)
Alternative NamebA528A10.3; IBRDC2; p53RFP; PIR2
Database LinkNP_877434
Entrez Gene 255488 Human
Function
Related PathwayTransmembrane

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

HEK293T cells transfected with either RC209302 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-RNF144B antibody(TA500712), and then analyzed by flow cytometry.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title